breast cancer chemoprevention postmenopause
Showing 1 - 25 of >10,000
Breast Tumor Trial in New York (RealRisks, BNAV)
Active, not recruiting
- Breast Neoplasm
- RealRisks
- BNAV
-
New York, New YorkColumbia University Medical Center
Aug 16, 2022
Breast Cancer Survivors, Postmenopause, Resistance Training Trial in Temuco (Prolonged resistance-type exercise training)
Not yet recruiting
- Breast Cancer Survivors
- +2 more
- Prolonged resistance-type exercise training
-
Temuco, ChileDepartment of Rehabilitation Sciences, Faculty of Medicine, Univ
Jan 9, 2023
Atypical Hyperplasia of the Breast, Lobular Breast Carcinoma In Situ, Pleomorphic Lobular Breast Carcinoma In Situ Trial in
Recruiting
- Atypical Hyperplasia of the Breast
- +2 more
- Cancer Educational Materials
- +3 more
-
Costa Mesa, California
- +48 more
Jan 9, 2023
Factors Influencing Decision-Making About Use of Chemoprevention
Completed
- Breast Cancer
- Counseling session
- +3 more
-
Houston, TexasMD Anderson Cancer Center
Oct 4, 2021
DCIS Trial in Orange (Anastrozole)
Completed
- DCIS
-
Orange, CaliforniaChao Family Comprehensive Cancer Center
Apr 19, 2021
Specialist Recommendation on FBC Chemoprevention Prescribing
Unknown status
- Familial Breast Cancer
- Survey Administration
-
Nottingham, United KingdomUniversity of Nottingham
Nov 10, 2020
Breast Tumors Trial in New York (RealRisks, BNAV)
Completed
- Breast Neoplasms
- RealRisks
- BNAV
-
New York, New YorkColumbia University Medical Center
Jan 7, 2021
Breast Cancer Trial in Milan (Tamoxifen, Placebo)
Active, not recruiting
- Breast Cancer
- Tamoxifen
- Placebo
-
Milan, ItalyEuropean Institute of Oncology
Aug 12, 2021
Breast Cancer Trial in Worldwide (anastrozole, )
Completed
- Breast Cancer
- anastrozole
- placebo
-
Newcastle, New South Wales, Australia
- +73 more
Oct 5, 2021
Breast Tumors Trial in Madison (Alendronate)
Terminated
- Breast Neoplasms
-
Madison, WisconsinUniversity of Wisconsin Carbone Cancer Center
Oct 20, 2020
Development ofQuantitative Tissue Optical Index of Breast
Withdrawn
- Accessory; Breast Tissue
- Breast Density
-
Costa Mesa, California
- +3 more
Oct 31, 2022
Breast Cancer, Lifestyle Risk Reduction Trial in London Borough of Sutton (Lifestyle intervention to reduce breast cancer risk)
Active, not recruiting
- Breast Cancer
- Lifestyle Risk Reduction
- Lifestyle intervention to reduce breast cancer risk
-
London Borough of Sutton, United KingdomThe Royal Marsden Hospital NHS Foundation Trust
Jan 17, 2023
Breast Cancer Trial in New York (RealRisks)
Not yet recruiting
- Breast Cancer
- RealRisks
-
New York, New YorkColumbia University Irving Medical Center
Apr 12, 2023
FH-Risk 2.0: Updating Breast Cancer Risk Estimates
Recruiting
- Breast Cancer Risk
- Notification of a revised breast cancer risk estimate
-
Manchester, Greater Manchester, United KingdomManchester University NHS Foundation Trust
Dec 17, 2022
Breast Cancer Trial in Manchester (BC-Predict, NHS Breast Screening Programme)
Completed
- Breast Cancer
- BC-Predict
- NHS Breast Screening Programme
-
Manchester, Greater Manchester, United KingdomManchester University NHS Foundation Trust
Jan 9, 2023
InheriteD brEast caNcer iTalian regIsTrY A
Recruiting
- Breast Cancer
-
Aviano, Pordenone, Italy
- +11 more
Apr 26, 2023
BRCA1 Mutation Carrier, BRCA2 Mutation Carrier, Ductal Breast Carcinoma in Situ Trial in Los Angeles (dietary supplement, other,
Active, not recruiting
- BRCA1 Mutation Carrier
- +8 more
- soy isoflavones
- +7 more
-
Los Angeles, CaliforniaUniversity of Southern California
Nov 11, 2021
Impact of Dietary Inflammatory Potential on Breast Cancer Risk
Not yet recruiting
- Breast Atypical Ductal Hyperplasia
- +4 more
- Follow-Up
- +2 more
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Dec 16, 2021
Solid Organ Transplant Recipients, Skin Cancer Trial in Australia (Sirolimus Topical Cream, Placebo)
Not yet recruiting
- Solid Organ Transplant Recipients
- Skin Cancer
- Sirolimus Topical Cream
- Placebo
-
Camperdown, New South Wales, Australia
- +5 more
May 8, 2023
Malaria Trial in Kwara (Standard age based SPAQ administration for SMC)
Recruiting
- Malaria
- Standard age based SPAQ administration for SMC
-
Kwara, NigeriaKwara Sentinell Site
Jul 31, 2023
Stage 0 Breast Cancer AJCC v6 and v7, Stage I Breast Cancer AJCC v7, Stage IA Breast Cancer AJCC v7 Trial in Italy, United
Active, not recruiting
- Stage 0 Breast Cancer AJCC v6 and v7
- +6 more
- Exemestane
- +6 more
-
Tampa, Florida
- +4 more
Dec 15, 2021
Breast MRI Utilization Among Patients at Elevated Risk
Active, not recruiting
- Breast Cancer
- Self-Report Survey
- Qualitative Interviews
-
Washington, District of Columbia
- +1 more
May 27, 2022
Breast Cancer, Breast Carcinoma, Breast Tumors Trial in Stockholm (Tamoxifen 20 mg)
Active, not recruiting
- Breast Cancer
- +4 more
- Tamoxifen 20 mg
-
Stockholm, SwedenKarolinska University Hospital
May 24, 2022
Colorectal Cancer, Colorectal Adenoma, Colorectal Adenomatous Polyp Trial in Calgary (acetylsalicylic acid delayed release
Not yet recruiting
- Colorectal Cancer
- +2 more
- acetylsalicylic acid delayed release tablets, 81mg
-
Calgary, Alberta, CanadaForzani & Macphail Colon Cancer Screening Centre, University of
May 27, 2022